Genoptix Downgraded To Neutral

September 22, 2010 9:56 AM | 8 seconds read | Make a Comment

Genoptix, Inc.

GXDX

has been downgraded by Wedbush from Outperform to Neutral with a lowered price target of $16 from $23.

Posted In: News Downgrades Analyst Ratings genoptix Health Care Health Care Services Wedbush

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.